doi: 10.1177/1352458519872652 26 RezaeizadehHMohammadpourZBitarafanSHarirchianMHGhadimiMHomayonIA
Adherence Analysis: Semaglutide QW Versus Other GLP-1 RAs As a result of the relatively short period of time from the launch of semaglutide QW to the index date, fewer patients receiving semaglutide QW were included in the adherence analysis at both 180 and 360 days ( n = 447 and n = 87, respectively), compared with patients receiving dulaglutide ( n = 17,073 and n = 7280, respectively) (Table 2), liraglutide ( n = 11,996 and n = 6137, respectively), and exenatide QW ( n = 5842 and n = 2683, respectively)
The company is also advancing MET-233i, an ultra-long-acting injectable amylin analog designed for combination therapy with MET-097i
-SMA upregulation indicates fibroblast activation, subsequent myofibroblast transformation, and increased cardiac fibrosis 42
Why Medicare Cant Stay On The Sidelines Policymakers have largely avoided Medicare in this debate so far, but they wont be able to indefinitely